Additional European equity stories post the release of the Daily European equity opening news

AstraZeneca (AZN LN) – Q3 core EPS USD 0.71 vs. Exp. USD 0.65, revenue USD 5.34bln vs. Exp. USD 5.12bln. Co. states they are on track for FY 2018 guidance. Co. sees FY core EPS in the range of USD  3.30-3.50 vs. Exp. USD 3.88. Co. sees FY product sales with low single digit percentage increase. (Newswires)

J Sainsbury (SBRY LN) – H1 adj. pretax GBP  302mln vs. Exp. GBP 278mln. Adj. operating profit GBP 351mln vs. Exp. 326mln. Interim dividend of GBP 0.031. H1 sales +3.5% to GBP 16.88bln. Underlying profit before tax growth of 20%. Retail sales (ex-fuel) +1.2%. Co. says food sales (+1.2%) and general merchandise sales (+1.5%) benefitted from hot summer. Co. is on track to deliver 2018-19 targets. (Newswires)

Burberry (BRBY LN) – H1 revenue GBP 1.22bln vs. Exp. GBP 1.2bln, adj. Operating profit GBP 178mln vs. Prev. GBP 185mln. (Newswires)

BAE Systems (BA/ LN) – Co. says FY outlook. Expects EPS in like with 2017 with minor FX tailwinds. Brexit near-term impact is likely limited. (Newswires)

Continental (CON GY) – Q3 revenue EUR 10.8bln vs. Exp. EUR 10.8bln. EBITDA +10.8% to EUR 1.4bln. Adj. operating profit -30.1% to EUR 772mln. FY guidance unchanged. (Newswires)

ASML (ASML NA) – Co. now look for net sales growth of around EUR 13bln by 2020 vs. Prev. view of EUR 11bln. (Newswires)

Duerr (DUE GY) – Q3 EBITDA -5.4%. Q3 revenue 6.2%. Q3 operating margin is within the target range at 6.9%. The Co say order intake and sales could reach new record levels in 2018. (Newswires)

Wienerberger (WIE AV) – Q3 revenue EUR 888.1mln, increase of 7%. Q3 adjusted EBITDA EUR 142.2MLN, increase of 13%. 9-month revenue EUR 2.5bln, up 6%. 9-month adjusted EBITDA EUR 356mln. The Co have confirmed their 2018 earnings forecast. (Newswires)

Lagardere (MMB FP) – Q3 revenue EUR 1.89bln vs. Prev. EUR 1.86bln. Co. confirmed 2018 EBIT guidance. (Newswires)

Tate & Lyle (TATE LN) – HY adj. pretax profit GBP 166mln vs GBP 1.66mln. HY sales from continuing operations GBP 1.383bln vs. Exp. GBP 1.398bln. Co. reaffirms FY guidance. (Newswires)

National Grid (NG/ LN) – HY underlying operating profit GBP 1.3bln vs. GBP 1.4bln. Net debt increased to GBP 25.6bln in 6 months, GBP 2.6bln greater than in March 2018. The Co are on track to achieve asset growth at the top end of the 5-7% medium term range, also implementing a cost efficiency and restructuring programme in the UK. (Newswires)

Sodexo (SW FP) – FY 2017/18 revenue EUR 20.4bln vs. Exp. EUR 20.4bln. Dividend EUR 2.75 vs. Prev. EUR 2.75. Co. reiterated revenue growth target. (Newswires)

Skanska (SKAB SS) – 9-month revenue SEK 120.8bln vs. prev. SEK 117.2bln. 9-month order bookings in construction SEK 102.6bln, decrease of 13%. The Co say Swedish residential building market is slowing down from a high activity level; and in the US the overall market is strong. (Newswires)

Subsea 7 SA (SUBC NO) – Q3 revenue USD 1.08bln vs. exp. USD 1.10bln. Q3 adjusted EBITDA USD 217mln vs. exp. USD 210mln. Q3 net profit USD 76mln vs. exp. USD 76mln. The Co say guidance is unchanged for the full year 2018, new guidance for 2019 forecasts revenue and adjusted EBITDA lower than 2018 levels. (Newswires)

Inmarsat (ISAT LN) – Quarterly revenue USD 369.3mln vs. Prev. USD 356.2mln. revenue USD 336.4mln, EBITDA USD 173.6mln. Co. says guidance is in line with market consensus. (Newswires)

Hikma Pharmaceuticals (HIK LN) – Co. raised FY guidance. (Newswires)